Villers-lès-Nancy, le 05 juin 2015 - 18h00 (CET)
PRESS RELEASE
On-line availability of Meeting Materials
for the Annual Ordinary and Extraordinary General Meeting
on June 26, 2015
The shareholders of PHARMAGEST INTERACTIVE are invited to attend the Annual Ordinary and Extraordinary General Meeting that will be held on Friday, June 26, 2015 at 5.00 pm, at headquarters located in VILLERS-LES-NANCY (54600), 5 allée de Saint Cloud.
The Preliminary Notice of Meeting, including the agenda, the draft resolutions the Board of Directors submits to the vote of the shareholders, as well as information concerning the Shareholders' Meeting attendance and voting procedures, was published in the BALO (Bulletin des Annonces Légales et Obligatoires) of May 20, 2014.
Pursuant to article R. 225-73-1 of the French commercial code, the Meeting Materials as well as the form of proxy are available on the company's web site : www.pharmagest.com, Investor Relations, since June 5, 2015.
The Notice of Meeting will be published in the BALO, in the Official Journal "Tablettes Lorraines" and on the company's website on June 8, 2015.
About the PHARMAGEST Group:
The PHARMAGEST Group is the French leader in information technology for pharmacies, with a 43.5% market share, 9,800 clients and more than 800 employees. Since September 2007, the PHARMAGEST Group has also been present in Northern Europe with a 12% market share in Belgium and Luxembourg through its SABCO subsidiary.
As a privileged partner to pharmacists for more than 30 years now, the PHARMAGEST Group designs innovative computer solutions for pharmacies and is developing a high-potential E-Business E-Media activity intended for laboratories.
The PHARMAGEST Group is also developing innovative new solutions for Retirement Homes (Care Comes and day centres for the elderly) through its subsidiary MALTA INFORMATIQUE.
The first Logiciel de Gestion à Portail Intégré (Integrated Portal Management Software - LGPI Global Services®), creator of value for the patient, pharmacist and laboratory, boosts sales, optimizes purchases and improves patient advice. It is also the first permanent-impact medium for pharmacies that provides laboratories with a direct means of communication with the pharmacist and his or her patients.
Operating at the heart of the digital revolution that is gradually establishing itself in the daily life of healthcare professionals and patients alike, at the beginning of 2012 the PHARMAGEST Group created an e-Health business, bringing together subsidiaries DIATELIC (telemedicine and e-health solutions) and DOMEDIC EUROPE (DO-Pill SecuR(TM) intelligent pill dispenser) and KAPELSE (electronic health devices).
Listed on Euronext Paris(TM) - Compartment B
Indices: ENTERNEXT TECH 40, CAC ® SMALL and CAC ® All-Tradable by inclusion
Eligible for the Long-Only Deferred Settlement Service (SRD)
ISIN : FR 0000077687 - Reuters : PHA.PA - Bloomberg : - PMGI FP
PHARMAGEST shares are eligible for France's Equity Savings Plan intended to finance SMEs (PEA-PME)
Find out the latest news from the group at www.pharmagest.com
CONTACTS
Analyst Investor Relations:
Chief Financial Officer: Jean-Yves SAMSON
Telephone: +33(0)3 83 15 90 67 - jean-yves.samson@pharmagest.com
Press Relations:
FIN'EXTENSO - Isabelle Aprile
Telephone: +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr
